We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+12.82%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$6.37B
AUM Growth
+$1.11B
Cap. Flow
+$527M
Cap. Flow %
8.27%
Top 10 Hldgs %
34.58%
Holding
1,211
New
40
Increased
703
Reduced
424
Closed
39

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$34.5M
2
AAPL icon
Apple
AAPL
+$29.1M
3
BAC icon
Bank of America
BAC
+$21.6M
4
AMZN icon
Amazon
AMZN
+$21M
5
TSLA icon
Tesla
TSLA
+$12.7M

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$6.12M
2
EL icon
Estee Lauder
EL
+$5.61M
3
CARR icon
Carrier Global
CARR
+$5.1M
4
GIS icon
General Mills
GIS
+$4.64M
5
TJX icon
TJX Companies
TJX
+$4.56M

Sector Composition

Rank Sector Weight
1 Technology 32.37%
2 Consumer Discretionary 14.58%
3 Healthcare 11.36%
4 Financials 10.36%
5 Communication Services 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCO icon
1151
Clear Channel Outdoor Holdings
CCO
$1.22B
$57K ﹤0.01%
17,120
+43
+0.3% +$134
SENS icon
1152
Senseonics Holdings Inc
SENS
$497M
$54K ﹤0.01%
1,018
+1
+0.1% +$65
TELL
1153
DELISTED
Tellurian Inc.
TELL
$54K ﹤0.01%
17,434
+527
+3% +$1.87K
MNKD icon
1154
MannKind Corp
MNKD
$1.31B
$51K ﹤0.01%
11,625
+36
+0.3% +$167
BNGO icon
1155
Bionano Genomics
BNGO
$14.3M
$41K ﹤0.01%
23
+1
+5% +$2.67K
IVR icon
1156
Invesco Mortgage Capital
IVR
$799M
$41K ﹤0.01%
1,490
+115
+8% +$3.56K
UEC icon
1157
Uranium Energy
UEC
$6.74B
$41K ﹤0.01%
12,106
+1,285
+12% +$4.95K
ENDP
1158
DELISTED
Endo International plc
ENDP
$41K ﹤0.01%
10,841
+70
+0.6% +$339
DHC
1159
Diversified Healthcare Trust
DHC
$1.9B
$35K ﹤0.01%
11,214
+81
+0.7% +$262
GSAT icon
1160
Globalstar
GSAT
$10.6B
$34K ﹤0.01%
1,926
+37
+2% +$811
AGEN
1161
Agenus
AGEN
$352M
$33K ﹤0.01%
+526
New +$41.5K
IDEX
1162
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$25K ﹤0.01%
165
+9
+6% +$1.92K
DFTX
1163
Definium Therapeutics
DFTX
$5.89B
$23K ﹤0.01%
1,099
+8
+0.7% +$255
GERN icon
1164
Geron
GERN
$983M
$18K ﹤0.01%
14,480
+254
+2% +$364
TOON icon
1165
Kartoon Studios
TOON
$39.9M
$14K ﹤0.01%
1,332
+1
+0.1% +$13
ASXC
1166
DELISTED
Asensus Surgical, Inc.
ASXC
$12K ﹤0.01%
11,050
+50
+0.5% +$77
DRRX
1167
DELISTED
DURECT Corp
DRRX
$11K ﹤0.01%
1,072
+12
+1% +$133
NMTR
1168
DELISTED
9 Meters Biopharma
NMTR
$11K ﹤0.01%
539
+12
+2% +$268
TNXP icon
1169
Tonix Pharmaceuticals
TNXP
$233M
0
TXMD icon
1170
TherapeuticsMD
TXMD
$25.7M
$7K ﹤0.01%
368
+1
+0.3% +$30
IBIO icon
1171
iBio
IBIO
$69.5M
$6K ﹤0.01%
21
+1
+5% +$381
EMWP
1172
DELISTED
Eros Media World PLC
EMWP
$4K ﹤0.01%
759
+10
+1% +$114
ALKS icon
1173
Alkermes
ALKS
$8.2B
-8,217
Closed -$253K
APO icon
1174
Apollo Global Management
APO
$78.8B
-20,615
Closed -$1.27M
BBIO icon
1175
BridgeBio Pharma
BBIO
$15.4B
-5,053
Closed -$237K

Similar funds

Xponance's Q4 2021 Portfolio in Review

As of Q4 2021, Xponance held 1,211 positions worth $6.37B, up 21% from $5.27B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Xponance deployed $527M of net new capital in Q4 2021, opening 40 new positions and adding to 703 existing holdings. Its largest new stake was Wolfspeed: 12,874 shares worth $1.44M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Entergy, an estimated $6.12M trimmed.

  • Xponance's largest Q4 2021 buy was Wolfspeed: 12,874 shares worth $1.44M.
  • Xponance added most to Microsoft in Q4 2021, an estimated $34.5M increase.
  • Xponance's biggest Q4 2021 reduction was Entergy, cutting an estimated $6.12M.
  • Xponance fully exited Kansas City Southern in Q4 2021, selling an estimated $1.91M.
  • Xponance's ten largest holdings make up 35% of its $6.37B portfolio in Q4 2021.
  • Xponance opened 40 new positions and closed 39 in Q4 2021.
  • Xponance's portfolio value rose 21% quarter-over-quarter to $6.37B.

Based on Xponance's 13F filing for Q4 2021, filed 31 Jan 2022.